Biotech, Food & Drug

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
3
2016
Amgen Launches Enbrel Biosimilar Patent Litigation Foley & Lardner LLP
Mar
2
2016
Kyle Bass’ Another Three IPRs: Targeting Anacor Mintz
Mar
2
2016
Genetically Modified (GM) Labeling Bill Clears Committee Keller and Heckman LLP
Mar
1
2016
Ohio Federal Court Invalidates Cleveland Clinic Diagnostic Patents On Motion To Dismiss Foley & Lardner LLP
Mar
1
2016
Salt Shake-up: Sodium Warning Labels Keller and Heckman LLP
Mar
1
2016
Companies to Pay Heavy Fine for Weight Loss Products Proskauer Rose LLP
Feb
29
2016
For Your Eyes Only: Protecting The IP Rights of #FoodPorn Valparaiso University Law
Feb
29
2016
Spice Safety Spotlight re: Food Law Keller and Heckman LLP
Feb
29
2016
Agencies Engaged in Federal Biotech Overhaul to Host Final Two Public Sessions in March Mintz
Feb
26
2016
No More Fishy Claims: FDA Guidance Prohibits Certain Claims for Omega-3 Fatty Acids Morgan, Lewis & Bockius LLP
Feb
26
2016
Tax Filing Season Alert: Exercise Caution Before Signing a Tax Return for a Marijuana Business Varnum LLP
Feb
26
2016
New GE Ingredient Labeling Bill Intensifies Food Fight in Congress Mintz
Feb
26
2016
Salt Signage Showdown Keller and Heckman LLP
Feb
25
2016
FDA Highlights Human Factors In Three Recently Issued Guidance Documents Morgan, Lewis & Bockius LLP
Feb
25
2016
Maple Wars re: Food Law Keller and Heckman LLP
Feb
24
2016
Fatty Acid Follow-Up: Food Law Keller and Heckman LLP
Feb
23
2016
Roundup Roundup re: Carcinogenic Herbicides Keller and Heckman LLP
Feb
22
2016
Vermont GM Guide (Part Deux) re: Food Labeling Law Keller and Heckman LLP
Feb
22
2016
The UK Psychoactive Substances Act 2016: An Example of Poor Drafting and Unintended Consequences for Food? Covington & Burling LLP
Feb
22
2016
U.S. President Announces Upcoming Trips to Cuba, Argentina, Vietnam and Laos Squire Patton Boggs (US) LLP
Feb
22
2016
Senate Cloture Vote Scheduled for FDA Nominee, Chamber May Consider Opioid Legislation Squire Patton Boggs (US) LLP
Feb
19
2016
Preemption Defense in the Ninth Circuit Is “Not Dead Yet” Mintz
Feb
19
2016
Cutting Corners in Cheese Keller and Heckman LLP
Feb
18
2016
California Provision Goes Slack re: Food Law Keller and Heckman LLP
Feb
18
2016
Sandoz Asks Supreme Court To Reverse Biosimilar Decision Foley & Lardner LLP
Feb
17
2016
FDA Aims to Expand Sentinel Capabilities, Include Evaluation of Drug Effectiveness McDermott Will & Emery
Feb
17
2016
60-Day Rule Is Final: Assessing Your Organization’s Safeguards Morgan, Lewis & Bockius LLP
Feb
17
2016
CMS Relaxes 60-day Overpayment “Look Back” Period for Medicare Providers Barnes & Thornburg LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins